Cart summary

You have no items in your shopping cart.

AKT inhibitor VIII

SKU: orb1224461

Description

A selective, allosteric Akt inhibitor with IC50 of 58/210 for Akt1/2 respectively; shows weak activity for Akt3 (IC50=2.12 uM); inhibits basal and IGF stimulated Akt1 and Akt2 phosphorylation in mouse lung, with no effect on Akt3 phosphorylation.

Images & Validation

Key Properties

CAS Number612847-09-3
MW551.6404
Purity>98% (HPLC)
FormulaC34H29N7O
SMILESO=C1N(C2CCN(CC3=CC=C(C4=NC5=CC6=C(N=CN6)C=C5N=C4C7=CC=CC=C7)C=C3)CC2)C8=CC=CC=C8N1
TargetAkt
Solubility10 mM in DMSO

Bioactivity

In Vivo
Mice are dosed with AKT inhibitor VIII (50 mpk, 3 doses, ip, every 90 min) achieving plasma concentrations of 1.5-2.0 μM, and then the animals are tail vein injected with IGF to stimulate Akt phosphorylation. By IP Western, both basal and IGF stimulated Akt1 and Akt2 phosphorylation are inhibited in mouse lung, with no effect on Akt3 phosphorylation.
In Vitro
When LnCaP cells are pretreated with AKT inhibitor VIII and then incubated with TRAIL, a dramatic increase in caspase-3 activity (6-10-fold relative to control or TRAIL alone) is observed. This sensitization of tumor cell lines with AKT inhibitor VIII is not limited to LnCaP cells as similar apoptosis induction is observed in HT29, MCF7, and A2780 cells, among others, with chemosensitizers such as camptothecin, herceptin, and doxorubicin. The furanodiene-induced decrease of p-Akt and Akt expressions is enhanced by the Akt inhibitor VIII pretreatment. Furthermore, the furanodiene-induced PARP cleavage is enhanced by Akt inhibitor VIII pretreatment. The Akt inhibitor VIII shows no effect on cleaved PARP expression but decreases the p-Akt and Akt expressions. AKT inhibitor VIII decreases cell viability and increases phosphatidylserine (PS) translocation to the outer leaflet of the plasma membrane, DNA fragmentation, Caspase-9 cleavage, Caspase-3 activation and PARP proteolysis in hESC lines WA01 (H1) and WA09 (H9) and in a hiPSCs cell line generated in our laboratory (FN2.1).

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

AKT inhibitor VIII | AKT-inhibitor-VIII | AKT inhibitor-8 | AKT-inhibitor-8 | Akt-I 1,2 | Akti-1/2. Sigma-A6730

Similar Products

  • AKT inhibitor VIII [orb1304301]

    98.65%

    612847-09-3

    551.64

    C34H29N7O

    2 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO), 5 mg, 10 mg, 25 mg
  • Furanodiene [orb1940929]

    >98% (HPLC)

    19912-61-9

    216.15

    C15H20O

    1 g, 500 mg, 200 mg, 100 mg, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

AKT inhibitor VIII (orb1224461)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 100.00
5 mg
$ 160.00
10 mg
$ 210.00
25 mg
$ 360.00
50 mg
$ 560.00
100 mg
$ 810.00